ABERCROMBIE GEORGE B
Insider CIK 1485939 · THRX Sr. VP, Corp. Partnerships · TZYM Director · BBI CHIEF EXECUTIVE OFFICER, Director · BCRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-06-12 | 2024-06-14 | 49,933 | — | $0 | 49,933 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-06-12 | 2024-06-14 | 6,820 | — | $0 | 36,431 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-06-13 | 2023-06-15 | 39,072 | — | $0 | 39,072 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-06-13 | 2023-06-15 | 16,745 | — | $0 | 29,611 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-06-07 | 2022-06-09 | 30,022 | — | $0 | 30,022 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-06-07 | 2022-06-09 | 12,866 | — | $0 | 12,866 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2022-04-18 | 2022-04-20 | 5,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2022-04-18 | 2022-04-20 | 5,000 | $3.32 | $16.6K | 5,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-04-18 | 2022-04-20 | 5,000 | $11.04 | $55.2K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2022-02-15 | 2022-02-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-02-15 | 2022-02-16 | 5,000 | $18.50 | $92.5K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2022-02-15 | 2022-02-16 | 5,000 | $3.32 | $16.6K | 5,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-11-15 | 2021-11-17 | 5,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-11-15 | 2021-11-17 | 5,000 | $3.32 | $16.6K | 5,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-11-15 | 2021-11-17 | 5,000 | $12.27 | $61.4K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-09-15 | 2021-09-17 | 5,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-09-15 | 2021-09-17 | 5,000 | $2.63 | $13.2K | 5,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-09-15 | 2021-09-17 | 5,000 | $15.06 | $75.3K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-09-10 | 2021-09-14 | 11,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-09-10 | 2021-09-14 | 30,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-09-10 | 2021-09-14 | 30,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-09-10 | 2021-09-14 | 30,000 | $2.91 | $87.3K | 74,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-09-10 | 2021-09-14 | 11,000 | $1.71 | $18.8K | 14,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-09-10 | 2021-09-14 | 30,000 | $3.22 | $96.6K | 44,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-09-10 | 2021-09-14 | 74,000 | $15.09 | $1.12M | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-07-15 | 2021-07-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-07-15 | 2021-07-19 | 5,000 | $2.63 | $13.2K | 8,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-07-15 | 2021-07-19 | 5,000 | $15.69 | $78.5K | 3,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-05-25 | 2021-05-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-24 | 2021-05-26 | 6,667 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-24 | 2021-05-26 | 6,667 | $2.63 | $17.5K | 9,667 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-05-24 | 2021-05-26 | 6,667 | $13.90 | $92.7K | 3,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-05-10 | 2021-05-12 | 7,000 | $12.70 | $88.9K | 3,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-05-12 | 2020-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-02-14 | 2020-02-19 | 8,764 | $1.16 | $10.2K | 8,764 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-02-14 | 2020-02-19 | 2,167 | $1.16 | $2.5K | 2,167 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-05-29 | 2019-05-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2018-08-21 | 2018-08-22 | 8,000 | $14.11 | $112.9K | 285,479 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2018-08-20 | 2018-08-22 | 5,680 | $14.08 | $80.0K | 293,479 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-06-20 | 2018-06-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2018-05-21 | 2018-05-22 | 8,000 | $14.40 | $115.2K | 299,159 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2018-05-20 | 2018-05-22 | 4,682 | $14.59 | $68.3K | 305,235 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2018-03-02 | 2018-03-06 | 74,444 | — | $0 | 309,917 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2018-02-21 | 2018-02-22 | 8,000 | $16.51 | $132.1K | 235,473 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2018-02-20 | 2018-02-22 | 15,500 | $16.44 | $254.8K | 243,473 | SEC↗ |
| INVA Innoviva, Inc. | S Sale | 2017-11-21 | 2017-11-22 | 5,215 | $13.26 | $69.2K | 258,651 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2017-11-20 | 2017-11-22 | 3,358 | $13.17 | $44.2K | 263,866 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2017-08-20 | 2017-08-22 | 2,886 | $12.28 | $35.4K | 267,224 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-05-24 | 2017-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2017-05-20 | 2017-05-23 | 2,228 | $11.86 | $26.4K | 270,110 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2017-02-20 | 2017-02-22 | 5,355 | $12.04 | $64.5K | 269,838 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2017-01-17 | 2017-01-19 | 106,718 | — | $0 | 275,193 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2016-11-20 | 2016-11-22 | 1,273 | $10.91 | $13.9K | 168,475 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2016-08-20 | 2016-08-23 | 1,939 | $11.79 | $22.9K | 169,463 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2016-05-20 | 2016-05-20 | 1,276 | $11.09 | $14.2K | 171,402 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2016-02-19 | 2016-02-23 | 5,376 | $12.28 | $66.0K | 170,178 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2016-01-14 | 2016-01-19 | 92,587 | — | $0 | 175,554 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-05-20 | 2015-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2015-01-07 | 2015-01-09 | 71,429 | — | $0 | 81,429 | SEC↗ |
| THRX THERAVANCE INC | A Award deriv | 2014-06-19 | 2014-06-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| THRX THERAVANCE INC | A Award | 2014-06-19 | 2014-06-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-05-02 | 2014-05-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-31 | 2014-04-01 | 4,000 | — | $0 | 11,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-31 | 2014-04-01 | 4,000 | $1.71 | $6.8K | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2013-11-12 | 2013-11-13 | 3,000 | $6.19 | $18.6K | 6,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-05-31 | 2013-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2013-03-05 | 2013-03-06 | 3,000 | $1.23 | $3.7K | 3,000 | SEC↗ |
| TZYM TRANZYME INC | A Award deriv | 2012-08-07 | 2012-08-09 | 31,835 | — | $0 | 31,835 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2012-05-23 | 2012-05-25 | 15,000 | — | $0 | 15,000 | SEC↗ |